АНТИБИОТИКО-АССОЦИИРОВАННЫЕ ДИАРЕИ И CL. DIFFICILE-ИНФЕКЦИЯ У ДЕТЕЙ: ФАКТОРЫ РИСКА
https://doi.org/10.22627/2072-8107-2015-14-2-30-34
Аннотация
Об авторах
Л. Н. МазанковаРоссия
д.м.н., проф., зав. каф. детских инфекционных болезней ГБОУ ДПО РМАПО МЗ РФ; 125373, г. Москва, ул. Героев Панфиловцев, д.28; +7 (495) 949-17-22
С. Г. Перловская
Россия
Список литературы
1. Баранов А.А. Применение антибиотиков у детей в амбулаторной практике. Методические рекомендации /А.А. Баранов, Л.С. Страчунский // Клиническая микробиология и антимикробная химиотерапия. — 2007. — № 9 (3). — С. 200—210. Baranov A.A., Strachunskiy L.S. [Antibiotics use in children in outpatient practice] / Metodic recommendations // Clinical Microbiology and Antimicrobial Chemotherapy. — 2007. — 9 (3) : S. 200—210. (In Russ)
2. Sommet A., Sermet C., Boelle P.Y., Tafflet M., Bernède C. et al. (2004) No significant decrease in antibiotic use from 1992 to 2000, in the French community // J. Antimicrob Chemother 54 : 524—528.
3. Бельмер С.В. Антибиотик-ассоциированный дисбактериоз кишечника // РМЖ. — 2004. — Т. 12 : 3. — С. 148—151. Belmer S.V. Antibiotic-associated intestinal dysbacteriosis // RMJ. — 2004. — 12 (3) : 148—151. (In Russ)
4. Turke D., Bernet J. P., Marx J., Kemph H., Giard P., Welbaum O. et al. Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population // J. Pediatr Gastroenterol Nutr. — 2003. — 37 : 22—26.
5. Alam S., Muchataq M. Antibiotic associated diarrhea in children. // Indian Pediatr. — 2009. — Jun. — 46 (6) : 491—6.
6. Damrongmanee A., Ukarapol N., 2000: Incidence of antibiotic-associated diarrhea in a pediatric ambulatory care setting // J of the Med Assoc of Thailand. — 90 (3) : 513—517.
7. Hogenauer C., Hammer H.F., Krejs G.J., Reisinger E.C. Mechanisms and management of antibiotic — associated diarrhea // Clin. Infect. Dis. — 1998. — 27 : 702—10.
8. Hogenauer C., Langner C., Beubler E. et al. Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis // NEngl J. Med. — 2006. — 355 : 2418—26.
9. C. Hogenauer et al. Klebsiella oxytoca as a Causative Organism of Antibiotic-Associated Hemorrhagic Colitis // N Engl J. Med. Dec. — 7. — 2006. — 355 : 2418—26.
10. Лобзин Ю.В. Современные представления об инфекции Clostridium difficile / Ю.В. Лобзин, С.М. Захаренко, Г.А. Иванов // Клиническая микробиология и антимикробная химиотерапия. — 2002. — № 3. — Т. 4. — С. 200—232. Yu.V. Lobzin, S.M. Zakharenko, G.A. Ivanov. [Current Understanding of Clostridium difficile Infection] // Clin. Microb. and Antimicrob. Chemoth. — 2002. — № 3. — V. 4. — S. 200—232. (In Russ)
11. Bose S., Han K.W., Lee M.J., Kim H. (2013) Intestinal Protective Effects of Herbal-Based Formulations in Rats against Neomycin Insult. // Evid Based Complement Alternat Med. — 2013 : 161278
12. Малов В.А. Антибиотикоассоцированные диареи // Клиническая микробиология и антимикробная химиотерапия. — 2002. — № 1. — Т. 4. — С. 22—32. Malov V.A. [Antibiotic-Associated Diarrhea] // Clin. Microb. and Antimicrob. Chemoth. — 2002. — № 1. — V. 4. — S. 22—32. (In Russ)
13. David M.S., Donald H.A., Fabio B. Association Between Antibiotic Use and Primary Idiopathic Intussusception // Arch. Pediatr. Adolesc. Med. — 2003. — Suppl. 157 (1). — P. 54-59.
14. Acar J.F. A comparison of side effects of levofloxacin to other agents concerning the ecological and microbiological effects on normal human flora // Chemotherapy 2001. — 47 (3) : 15—23.
15. Бондаренко В.М. Метаболитные пробиотики: механизмы тера-певтического эффекта при микроэкологических нарушениях // Consilium Medicum. Гастроэнтерология. — 2005. — № 6. — Т. 7. — С. 437—443. Bondarenko V.M. [Metabolic probiotics: mechanisms of therapeutic effect in microecological disorders] // Consilium Medicum. Gastroenterology. — 2005. — № 6 (7). — S. 437—43. (In Russ)
16. Ардатская М.Д. Дисбактериозы кишечника: эволюция взглядов, cовременные принципы диагностики и фармакологическои коррекции / М.Д. Ардатская, О.Н. Минушкин // Consilium Medicum. Гастроэнтерология. — 2006. — № 2. — С. 4—17. Ardatskaya M.D., Minushkin O.N. [Dysbacteriosis of the intestine: evolution of views, modern principles of diagnosis and pharmacological correction] // Consilium Medicum. Gastroenterology. — 2006. — № 2. — S. 4—17. (In Russ)
17. M. Barakat, Z. El-Kady, M. Mostafa, N. Ibrahim, H. Ghazaly. Antibiotic-associated bloody diarrhea in infants: clinical, endoscopic, and histopathologic profiles // J. of Ped Gastroent and Nutr. — 52 (1). — 60—64.
18. Sparks S., Carman R.J., Sarker M., McLane B. Genotyping of enterotoxigenic Clostridium perfringens fecal isolates associated with antibiotic-associated diarrhea and food poisoning in North America // J Clin Microbiol. — 2001. — 39 (3) : 883—8.
19. Zollner-Schwetz I. et al. — 2008. Role of Klebsiella oxytoca in antibiotic-associated diarrhea // Clin. Infect. Dis. — 47: e74—e78.
20. Hoffmann K.M. et al. 2010. Antibiotic-associated hemorrhagic colitis caused by cytotoxin-producing Klebsiella oxytoca // Pediatrics. — 125: e960—e963.
21. Krause R., Schwab E., Bachhiesl D., Daxböck F., Wenisch C., Krejs G.J., Reisinger E.C. Role of Candida in antibiotic-associated diarrhea // J Infect Dis. — 2001. — Oct. 15. — 184 (8) : 1065—9. — Epub. — 2001. — Aug 31.
22. Krause R., Krejs G., Wenisch C., Reisinger E.C. Elevated fecal Candida counts in patients with antibiotic-associated diarrhea: role of soluble fecal substances // Clin and Diagn Lab Immunol. — 2003. — V. 10 (1). — 167—168.
23. Thomas C., Stevenson M., Riley T.V. (2003). Antibiotics and hospital acquired Clostridium difficile-associated diarrhoea: a systematic review of published epidemiological studies // J. of Antimic Chemoth. — 51 (6). — 1339—1350.
24. Захарова И.Н. Антибиотик-ассоциированные диареи у детей: проблема и решение. Учебное пособие для врачей / И.Н. Захарова, Л.Н. Мазанкова. - М., 2011. — 48 c. Zaharova I.N., Mazankova L.N. [Antibiotic-associated diarrhea in children the problem and the solution] (training manual for doctors). — Moscow. — 2011. — 48 s. (In Russ)
25. Захаренко С.М. Заболевания, ассоциированные с Clostridium difficile / С.М. Захаренко, С.В. Пономарев // Лечение и профилактика. — 2012. — № 3. — С. 82—89. Zakharenko S.M., Ponomarev S.V. [The diseases associated with Clostridium difficile] // Treatment and Prevention. — 2012. — № 3. — S. 82—89. (In Russ)
26. Britton R.A., Young V.B. 2012. Interaction between the intestinal micro-biota and host in Clostridium difficile colonization resistance // Trends Microbiol. — 20 : 313—319.
27. Kelly C.P., Kyne L. 2011. The host immune response to Clostridium difficile. // J. Med. Microbiol. — 60 : 1070—1079.
28. Loo V.G. et all. 2011. Host and pathogen factors for Clostridium difficile infection and colonization // N. Engl. J. Med. — 365 : 1693— 1703.
29. Morinville V., McDonald J. (2005) Clostridium difficile — associated diarrhea in 200 Canadian children // Can J Gastroenterol. — 19 (8) : 497—501.
30. Spivack J.G., Eppes S.C., Klein J.D. (2003) Clostridium difficile associated diarrhea in a pediatric hospital // Clin Pediatr (Phila). — 42 (4) : 347—52.
31. Klein E.J., Boster D.R., Stapp J.R., Wells J.G., Qin X. et al. (2006) Diarrhea etiology in a Children's Hospital Emergency Department: a prospective cohort study // Clin Infect Dis. — 43 (7) : 807—13.
32. Rupnik M., Wilcox M.H., Gerding D.N. (2009) Clostridium difficile infection: new developments in epidemiology and pathogenesis // Nature. — 7 : 526—36.
33. Dethlefsen L., Huse S., Sogin M.L., Relman D.A. 2008. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing // PLoS Biol. — 6:e280. doi: 10.1371/ journal.pbio. — 0060280.
34. Bartlett J.G. Clostridium difficile: progress and challenges // Ann N. Y. Acad Sci. — 2010. — 1213 : 62—69.
35. Denève C., Bouttier S., Dupuy B., Barbut F., Collignon A., Janoir C. Effects of subinhibitory concentrations of antibiotics on colonization factor expression by moxifloxacin-susceptible and moxifloxacin-resistant Clostridium difficile strains // Antimicrob Agents Chemother. — 2009. — Dec. — 53 (12) : 5155—62.
36. Razaq N. et al. Infection of hamsters with historical and epidemic BI types of Clostridium difficile // J. Infect Dis. — 2007. — 196 : 1813— 1819.
37. Stevens V. et al. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection // Clin Infect Dis. — 2011. — 53 : 42—48.
38. Юнес Б. Роль Clostrdium difficile в формировании антибиотик-ассоциированной диареи у детей: Автореф. ... к.м.н. - М., 2013. — 25 c. Yunes B. [Role Clostrdium difficile in the formation of antibiotic-associated diarrhea in children] (abstract). — M., 2013. — 25 s. (In Russ)
39. Paterson D.L. Collateral damage» from cephalosporin or quinolone antibiotic therapy // Clin Infect Dis. — 2004. — 38 (Suppl 4). — S. 341—345.
40. Reeves A.E. et al. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection // Gut Microbes. — 2011. — 2 : 145—158.
41. Rea M.C. et al. Microbes and Health Sackler Colloquium: Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon // Proc Natl Acad Sci USA. — 2010.
42. Theriot C.M., Koenigsknecht M.J., Carlson P.E. Jr, Hatton G.E., Nelson A.M., Li B., Huffnagle G.B., Z Li J., Young V.B. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection // Nat Commun. — 2014. — 5 : 3114.
43. Dethlefsen L., Relman D.A. 2011. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation // Proc. Natl. Acad. Sci. U.S.A. — 108 (Suppl 1) : 4554—4561.
44. Gough E., Shaikh H., Manges A. R. 2011. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection // Clin. Infect. Dis. — 53 : 994—1002.
45. Van Nood E et al. 2013. Duodenal infusion of donor feces for recurrent Clostridium difficile // N. Engl. J. Med. — 368 : 407—415.
46. Maribeth R. Nicholson, Isaac P. Thomsen and Kathryn M. Edwards. Controversies Surrounding Clostridium difficile Infection in Infants and Young Children // Children. — 2014. — 1 (1). — 40—47.
47. Jarchum I. et al. Toll-like receptor-5 stimulation protects mice from acute Clostridium difficile colitis // Infect Immun. — 2011. — 79 : 1498—1503.
48. Pai S., Aliyu S.H., Enoch D.A., Karas J.A. Five years experience of Clostridium difficile infection in children at a UK tertiary hospital: proposed criteria for diagnosis and management // PLoS One. — 2012. — 7 (12): e51728.
49. Kim J., Smathers S.A., Prasad P. et al. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States. — 2001—2006 // Pediatrics. — 2008. — 122 : 1266—1270.
50. Adlerbertha I., Huangb H., Lindberga E. et al. Toxin-Producing Clostridium difficile Strains as Long-Term Gut Colonizers in Healthy Infants // J. Clin. Microbiol. January. — 2014. — V. 52. — № 1. — 173—179.
51. Jangi S., Lamont J.T. 2010. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life // J. Pediatr. Gastroenterol. — Nutr. 51:. — 2—7.
52. Magnusson C., Wullt M., Löfgren S., Iveroth P., Akerlund T., Matussek A. 2013. Ribotyping of Clostridium difficile strains associated with no-socomial transmission and relapses in a Swedish county // APMIS. — 121 : 153—157.
53. Bauer M.P., Notermans D.W., van Benthem B.H., Brazier J.S., Wilcox M.H., Rupnik M., Monnet D.L., van Dissel J.T., Kuijper E.J., ECDIS Study Group. — 2011. Clostridium difficile infection in Europe: a hospital-based survey // Lancet. — 377 : 63—73.
54. Khanna S. et all. The epidemiology of Clostridium difficile infection in children: a population-based study // Clin Infect Dis. — 2013. — May 56 (10) : 1401—6.
55. Penders J., Thijs C., Van den Brandt P. A., Kummeling I., Snijders B. et al. (2007) Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study // Gut. — 56 : 661—7.
56. Matsuki S., Ozaki E., Shozu M. et al. Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three daycare facilities of Kanazawa, Japan // Int Microbiol. — 2005. — 8 : 43—48.
57. Rousseau C. et al. Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition // J. Clin Microbiol. — 49 : 858—865 (2011).
58. Ling Z. et al. Pyrosequencing analysis of the human microbiota of healthy Chinese undergraduates // BMC Genomics. — 14.: 390 (2013).
59. Mariat D. et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age // BMC Microbiol. — 9 : 123 (2009).
60. Ling Z., Liu X., Jia X., Cheng Y. at all. 2014. Impacts of infection with different toxigenic Clostridium difficile strains on faecal microbiota in children // Sci Rep. — 2014. — Dec 15. —4 : 7485.
61. Tonooka T., Sakata S., Kitahara M. et al. Detection and quantification of four species of the genus Clostridium in infant feces // Microbiol Immunol. — 2005. — 49 : 987—992.
62. Щеплягина Л.А. Секреторный иммунитет кишечника у детей ран-него возраста / Л.А. Щеплягина, И.В. Круглова, В.А. Перцева // Педиатрия. — 2011. — № 3. — С. 48—50. Sheplygina L.A., Kruglova V.I., Pertseva V.A. [The secretory immune system of the intestine in children of early age] // Pediatrics. — 2011. — № 3. — S 48—50. (In Russ)
63. Penders J., Vink C., Driessen C. et al. Quantification of Bifidobacteri-um spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR.// FEMS Micro-biol Lett. — 2005. — 243 : 141—147.
64. Hopkins M.J., Macfarlane G.T. 2002. Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection // J. Med. Microbiol. — 51 : 448—454.
65. Эпидемиология и клинические варианты Clostridium difficile-инфекции у детей / Л.Н. Мазанкова, Б. Юнес, С.Г. Горбунов, И.С. Курох-тина // Детские инфекции. — 2012. — № 3. — С. 39—42. Mazankova L.N., Yunes В., Gorbunov S.G., Kurokhtina I.S. [Epidemiology and clinical variants of Clostridium difficile infection on the background of antimicrobial therapy in children] // Children Infections. — 2012. — № 3. — S. 39—42. (In Russ)
66. Bossuyt P., Verhaegen J., Van Assche G., Rutgeerts P., Vermeire S. Increasing incidence of clostridium difficile-associated diarrhea in inflammatory bowel disease // J. Crohn’s Colitis. — 2009. — 3 : 4—7.
67. Parsons S.J., Fenton E., Dargaville P. Clostridium difficile associated severe enterocolitis: a feature of Hirschsprung's disease in a neonate presenting late // J. of paed and child health. — 41 : 12. — 2005. — Dec. — Pg 689—90.
68. El-Mahallawy H.A., El-Din N.H., Salah F., El-Arousy M., El-Naga S. A. (2004) Epidemiologic profile of symptomatic gastroenteritis in pediatric oncology patients receiving chemotherapy // Pediatr Blood Cancer. — 42 (4) : 338—42.
69. Castagnola E., Battaglia T., Bandettini R., Caviglia I., Baldelli I. et al (2009) Clostridium difficile — associated disease in children with solid tumors // Support Care Cancer. — 17 (3) : 321—4.
70. Simon A., Fleischhack G., Hasan C., Bode U., Engelhart S. et al. (2000) Surveillance for nosocomial and central line related infections among pediatric hematologyoncology patients // Infect Control Hosp Epidemiol. — 21 (9) : 592—596.
Рецензия
Для цитирования:
Мазанкова Л.Н., Перловская С.Г. АНТИБИОТИКО-АССОЦИИРОВАННЫЕ ДИАРЕИ И CL. DIFFICILE-ИНФЕКЦИЯ У ДЕТЕЙ: ФАКТОРЫ РИСКА. ДЕТСКИЕ ИНФЕКЦИИ. 2015;14(2):29-34. https://doi.org/10.22627/2072-8107-2015-14-2-30-34
For citation:
Mazankova L.N., Perlovskaya S.G. ANTIBIOTIC-ASSOCIATED DIARRHEA AND CL. DIFFICILE-INFECTION IN CHILDREN: RISK FACTORS. CHILDREN INFECTIONS. 2015;14(2):29-34. (In Russ.) https://doi.org/10.22627/2072-8107-2015-14-2-30-34